Melanoma is the sixth most frequent malignancy. It represents 1.7% of all cancer cases
worldwide. Many risk factors are associated with melanoma including ultraviolet radiation …

Melanoma is the utmost fatal kind of skin neoplasms. Molecular changes occurring during
the pathogenic processes of initiation and progression of melanoma are diverse and include …

Melanoma is a life-threatening malignancy with poor prognosis and a relatively high burden
of mortality in advanced stages. The efficacy of current available therapeutic strategies is …

Melanoma is the less common but the most malignant skin cancer. Since the survival rate of
melanoma metastasis is about 10–15%, many different studies have been carried out in …

Malignant melanoma is a highly aggressive tumour with increasing incidence and poor
prognosis in the metastatic stage. In recent years, a substantial number of reports on …

Melanoma is the leading cause of skin cancer deaths in the United States, and its incidence
has been rising steadily for the past 30 years (Aftab, Dinger, & Perera, 2014). A more …

Malignant cutaneous melanoma is a highly aggressive form of skin cancer. Despite
improvements in early melanoma diagnosis, the 5-year survival rate remains low in …

Melanoma incidence and associated mortality continue to increase worldwide. The lack of
treatments with durable responses for stage IV melanoma may be due, at least in part, to an …

Abstract Analysis of microRNA (miRNA) biogenesis and function is an area of research that
started only recently but has subsequently accelerated tremendously. This is because of the …

Tumour metastasis is a multistep process. Melanoma is a highly aggressive cancer and
metastasis accounts for the majority of patient deaths. microRNAs (miRNAs) are non-coding …